newsfilter
← Latest News
GlobeNewswire·

Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds

Grand Cayman, May 15, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for